Abstract:Mateusz Szymczak, Piotr Golec Department of Molecular Virology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland Correspondence: Piotr Golec, University of Warsaw, Faculty of Biology, Institute of Microbiology, Department of Molecular Virology, Miecznikowa 1, Warsaw, Poland, Email The escalating threat of antibiotic-resistant bacteria, particularly those forming biofilm structures, underscores the urgent need for alternative treatment strategies. Bacteriophages have emerged as promising agents for combating bacterial infections, especially those associated with biofilm formation. However, the efficacy of phage therapy can be limited by the development of bacterial resistance and biofilm regrowth. Interestingly, phages could be combined with other agents, such as metal nanoparticles, to enhance their antibacterial effectiveness. Since the therapeutic strategy of using phages and metal nanoparticles has been developed relatively recently, evaluating its efficacy under various conditions is essential, with a particular focus on the duration of activity. This study tested the hypothesis that a novel approach to combating bacterial biofilms, based on phages armed with silver nanoparticles (AgNPs), would exhibit enhanced activity over an extended period after application. In this work, we investigated the potential of engineered T7 phages armed with AgNPs for eradicating Escherichia coli biofilm. We demonstrated that such biomaterial exhibits sustained antimicrobial activity even after prolonged exposure. Compared to phages alone or AgNPs alone, the biomaterial significantly enhances biofilm eradication, particularly after 48 hours of treatment. These findings highlight the potential of synergistic phage-nanoparticle strategies for combatting biofilm-associated infections. Keywords: bacteriophage T7, Escherichia coli , biofilm, silver nanoparticles Graphical The spread of antibiotic resistance in bacteria poses a danger to public health. 1 Multidrug-resistant bacteria (MDR), particularly those equipped with biofilm-forming capabilities, are potentially hazardous as they possess the ability to instigate chronic and recurrent infections. 2 Bacterial biofilm, the complex communities of microorganisms attached to surfaces and encased in an extracellular polymeric substance (EPS) matrix, is notoriously resistant to antibiotics and other antimicrobial treatments. 3 Furthermore, the biofilm structure has been found to facilitate the horizontal transfer of genetic material, contributing to the spread of antibiotic resistance genes. 4 Moreover, the architecture of biofilms not only allows microbial populations to colonize human and animal hosts but also enables their attachment to inert surfaces. These features have led to an increasing prevalence of infections linked to the use of biomaterials in both human and veterinary medical applications. 5 Consequently, considerable efforts are underway to develop alternative strategies for managing biofilm-forming MDR infections. 6 Bacteriophages (in short phages), commonly encountered viruses capable of infecting bacterial cells, offer significant potential in managing biofilm development and bacterial infections. 7–9 The use of diverse phages, often in the form of a phage cocktail, has been shown to effectively reduce biofilm growth on various surfaces, organic and inorganic alike, making a notable contribution to disease prevention. 8–10 However, recent studies have shown that biofilm can regrow after 24 hours of phage treatment, which may limit the effectiveness of phage therapy. A study 11–13 examined the efficacy of phages against biofilms formed by Escherichia coli, Listeria monocytogenes and Pseudomonas aeruginosa . The researchers discovered that phages significantly reduced the biofilm at 24 hours, but their effectiveness diminished by 48 hours. Other work reports while phages initially reduced the biofilm biomass, after 48 hours the biofilm had returned to its original level. 14,15 A similar observation was reported in the case of phage treatment of Acinetobacter baumannii and P. aeruginosa biofilms. 16,17 In this case, the biofilm's bacterial cells developed resistance to the phages over time. Combining phages with other treatment approaches, such as antibiotics, can potentially enhance therapeutic effects. 18 To date, much of the research on phage-antibiotic combinations has centered around P. aeruginosa , a well-known opportunistic pathogen often linked to cystic fibrosis, burn infections, hospital-acquired pneumonia, and urinary tract infections. 19 Another pathogenic bacterium of concern is E. coli , which is -Abstract Truncated-

The antibacterial and biofilm inhibition activity of encapsulated silver nanoparticles in emulsions and its synergistic effect with E. coli bacteriophage

Synergistic Effect of Silver Nanoparticles with Antibiotics for Eradication of Pathogenic Biofilms

Characterization, antibacterial, and cytotoxic activities of silver nanoparticles using the whole biofilm layer as a macromolecule in biosynthesis

Antibacterial, antibiofilm, and anticancer activity of silver-nanoparticles synthesized from the cell-filtrate of Streptomyces enissocaesilis

Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates

Silver Nanoparticle-Aminogylcosides Conjugation for Enhanced Control of Pathogenic E. Coli O157:H7

Antibiofilm efficacy of silver nanoparticles against biofilm of extended spectrum β-lactamase isolates of Escherichia coli and Klebsiella pneumoniae

Augmented Antibacterial Activity of Cefazolin with Silver Nanoparticles Against Staphylococcus Aureus and Escherichia Coli

Synergistic and Antagonistic Effects of Metal Nanoparticles in Combination with Antibiotics Against Some Reference Strains of Pathogenic Microorganisms

Long-Term Effectiveness of Engineered T7 Phages Armed with Silver Nanoparticles Against Escherichia coli Biofilm

Evaluation of bactericidal effects of silver hydrosol nanotherapeutics against Enterococcus faecium 1449 drug resistant biofilms

Synergistic antibacterial activity of compact silver/magnetite core-shell nanoparticles core shell against Gram-negative foodborne pathogens

Lethal Mechanisms of Nostoc-Synthesized Silver Nanoparticles Against Different Pathogenic Bacteria

Ciprofloxacin-Loaded Silver Nanoparticles as Potent Nano-Antibiotics against Resistant Pathogenic Bacteria

Development of pH-responsive nanocomposites with remarkably synergistic antibiofilm activities based on ultrasmall silver nanoparticles in combination with aminoglycoside antibiotics

An effective antibiofilm strategy based on bacteriophages armed with silver nanoparticles

Silver nanoparticles as an antimicrobial agent: A case study on Staphylococcus aureus and Escherichia coli as models for Gram-positive and Gram-negative bacteria.

Silver nanoparticles produced from Cedecea sp. exhibit antibiofilm activity and remarkable stability

In Vitro Antibacterial Activity of Silver Nanoparticles Conjugated with Amikacin and Combined with Hyperthermia against Drug-Resistant and Biofilm-Producing Strains

Green synthesized silver nanoparticles from Phoenix dactylifera synergistically interact with bioactive extract of Punica granatum against bacterial virulence and biofilm development

Silver nanoparticles synthesized by probiotic bacteria and antibacterial role in resistant bacteria